Trexquant Investment LP Nevro Corp Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Nevro Corp stock. As of the latest transaction made, Trexquant Investment LP holds 259,616 shares of NVRO stock, worth $1.18 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

259,616

Previous 117,625 120.71%

Holding current value

$1.18 Million

Previous $990,000 46.26%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.71 - $10.1 $668,777 - $1.43 Million	141,991 Added 120.71%	259,616 $1.45 Million
Q2 2024 Aug 13, 2024	BUY	$7.96 - $13.59 $195,386 - $333,580	24,546 Added 26.37%	117,625 $990,000
Q1 2024 May 14, 2024	BUY	$13.56 - $20.78 $888,003 - $1.36 Million	65,487 Added 237.34%	93,079 $1.34 Million
Q4 2023 Feb 09, 2024	SELL	$14.18 - $22.31 $18,448 - $29,025	-1,301 Reduced 4.5%	27,592 $593,000
Q3 2023 Nov 13, 2023	BUY	$18.22 - $25.85 $283,758 - $402,587	15,574 Added 116.93%	28,893 $555,000
Q2 2023 Aug 11, 2023	SELL	$22.62 - $39.32 $74,600 - $129,677	-3,298 Reduced 19.85%	13,319 $338,000
Q1 2023 May 15, 2023	SELL	$30.17 - $41.11 $2.17 Million - $2.95 Million	-71,761 Reduced 81.2%	16,617 $600,000
Q4 2022 Feb 13, 2023	BUY	$36.43 - $49.4 $3.22 Million - $4.37 Million	88,378 New	88,378 $3.5 Million
Q2 2022 Aug 11, 2022	BUY	$40.85 - $77.67 $832,155 - $1.58 Million	20,371 New	20,371 $893,000
Q1 2022 May 13, 2022	SELL	$59.95 - $92.06 $533,495 - $819,241	-8,899 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $721,441 - $1.08 Million	8,899 New	8,899 $721,000
Q2 2021 Aug 12, 2021	SELL	$141.6 - $179.06 $210,417 - $266,083	-1,486 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$132.81 - $182.18 $197,355 - $270,719	1,486 New	1,486 $207,000
Q3 2020 Nov 06, 2020	SELL	$114.09 - $145.51 $698,002 - $890,230	-6,118 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$89.45 - $129.85 $267,902 - $388,900	-2,995 Reduced 32.87%	6,118 $731,000
Q1 2020 May 08, 2020	SELL	$70.23 - $144.31 $61,732 - $126,848	-879 Reduced 8.8%	9,113 $911,000
Q4 2019 Feb 12, 2020	SELL	$76.41 - $117.54 $141,587 - $217,801	-1,853 Reduced 15.64%	9,992 $1.17 Million
Q3 2019 Nov 08, 2019	BUY	$61.52 - $91.1 $376,133 - $556,985	6,114 Added 106.68%	11,845 $1.02 Million
Q2 2019 Aug 09, 2019	SELL	$58.04 - $66.99 $973,272 - $1.12 Million	-16,769 Reduced 74.53%	5,731 $372,000
Q1 2019 May 13, 2019	SELL	$35.52 - $62.62 $90,078 - $158,804	-2,536 Reduced 10.13%	22,500 $1.41 Million
Q4 2018 Feb 13, 2019	BUY	$35.43 - $56.29 $147,176 - $233,828	4,154 Added 19.89%	25,036 $974,000
Q3 2018 Nov 09, 2018	BUY	$44.22 - $75.47 $923,402 - $1.58 Million	20,882 New	20,882 $1.19 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $161M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Nevro Corp Transaction History